Dan is an experienced trial lawyer and life sciences litigator focusing on high-stakes patent, trade secret and commercial disputes. He litigates matters involving a wide variety of complex technologies. In the life sciences, these include biosimilars and antibody drugs, agricultural tech and biofuels, cancer and antiviral medicines, and medical devices. Beyond life sciences, Dan has handled many cases for high-tech companies, in areas including autonomous vehicles, machine learning, semiconductor design, processor cooling, optics and software. Dan represents branded pharmaceutical companies in abbreviated new drug application (ANDA) litigation and both reference product and biosimilar companies in Biologics Price Competition and Innovation Act (BPCIA) litigation. He has tried cases in district courts across the United States, at the Patent Trial and Appeal Board (PTAB), the Delaware Court of Chancery and the International Trade Commission (ITC), and handled appeals at the US Court of Appeals for the Federal